Fonds de solidarit' FTQ invests US$4 million in Ventus Therapeutics

Published Apr 08 2021 at 11:00 AM GMT
Key
Points
  • Ventus' innovative technologies pave the way to develop new drugs for elusive therapeutic targets MONTR"AL, April 8, 2021 /CNW Telbec/ - "Fonds de solidarit' FTQ (the "?Fonds"") is investing US$4 million in Ventus Therapeutics.
  • Created in 2019 by Versant Ventures, Ventus is pioneering a unique approach to structure-based drug discovery to address biologically validated, but elusive, drug targets.
  • The company is rapidly advancing a pipeline of new medicines to treat autoimmune and inflammatory diseases, neurological disorders, and cancer.




Stats

  • Published Apr 8, 2021 11:00 AM GMT